Journal article
Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome. Insights from the LUNG SAFE Study
American journal of respiratory and critical care medicine, Vol.195(1), pp.67-77
01/01/2017
DOI: 10.1164/rccm.201606-1306OC
PMID: 27753501
Abstract
Noninvasive ventilation (NIV) is increasingly used in patients with acute respiratory distress syndrome (ARDS). The evidence supporting NIV use in patients with ARDS remains relatively sparse.
To determine whether, during NIV, the categorization of ARDS severity based on the Pa
/Fi
Berlin criteria is useful.
The LUNG SAFE (Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure) study described the management of patients with ARDS. This substudy examines the current practice of NIV use in ARDS, the utility of the Pa
/Fi
ratio in classifying patients receiving NIV, and the impact of NIV on outcome.
Of 2,813 patients with ARDS, 436 (15.5%) were managed with NIV on Days 1 and 2 following fulfillment of diagnostic criteria. Classification of ARDS severity based on Pa
/Fi
ratio was associated with an increase in intensity of ventilatory support, NIV failure, and intensive care unit (ICU) mortality. NIV failure occurred in 22.2% of mild, 42.3% of moderate, and 47.1% of patients with severe ARDS. Hospital mortality in patients with NIV success and failure was 16.1% and 45.4%, respectively. NIV use was independently associated with increased ICU (hazard ratio, 1.446 [95% confidence interval, 1.159-1.805]), but not hospital, mortality. In a propensity matched analysis, ICU mortality was higher in NIV than invasively ventilated patients with a Pa
/Fi
lower than 150 mm Hg.
NIV was used in 15% of patients with ARDS, irrespective of severity category. NIV seems to be associated with higher ICU mortality in patients with a Pa
/Fi
lower than 150 mm Hg. Clinical trial registered with www.clinicaltrials.gov (NCT 02010073).
Details
- Title: Subtitle
- Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome. Insights from the LUNG SAFE Study
- Creators
- Giacomo Bellani - University of Milano-BicoccaJohn G Laffey - University of TorontoTài Pham - Marie CurieFabiana Madotto - University of Milano-BicoccaEddy Fan - University of TorontoLaurent Brochard - University of TorontoAndres Esteban - Hospital Universitario de GetafeLuciano Gattinoni - Fondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoVesna Bumbasirevic - University of BelgradeLise Piquilloud - University of LausanneFrank van Haren - Australian National UniversityAnders Larsson - Uppsala UniversityDaniel F McAuley - Queen's University BelfastPhilippe R Bauer - Mayo Clinic Rochester, MNYaseen M Arabi - King Saud bin Abdulaziz University for Health SciencesMarco Ranieri - Sapienza University of RomeMassimo Antonelli - Università Cattolica del Sacro CuoreGordon D Rubenfeld - University of TorontoB Taylor Thompson - Harvard UniversityHermann Wrigge - University of LeipzigArthur S Slutsky - University of TorontoAntonio Pesenti - Fondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoLUNG SAFE InvestigatorsEuropean Society of Intensive Care Medicine (ESICM) Trials Group
- Contributors
- Nicholas M Mohr (Contributor) - University of Iowa, Anesthesia
- Resource Type
- Journal article
- Publication Details
- American journal of respiratory and critical care medicine, Vol.195(1), pp.67-77
- DOI
- 10.1164/rccm.201606-1306OC
- PMID
- 27753501
- NLM abbreviation
- Am J Respir Crit Care Med
- ISSN
- 1073-449X
- eISSN
- 1535-4970
- Language
- English
- Date published
- 01/01/2017
- Academic Unit
- Epidemiology; Emergency Medicine; Anesthesia; Injury Prevention Research Center
- Record Identifier
- 9984296131702771
Metrics
11 Record Views